{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:32:38Z","timestamp":1789075958006,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41401-026-01826-5","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T03:15:13Z","timestamp":1779074113000},"page":"1944-1954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["USP22 deubiquitinates and stabilizes ERK1\/2 to promote colorectal cancer progression"],"prefix":"10.1038","volume":"47","author":[{"given":"Guang-chao","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-gang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-mei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"1826_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1826_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(24)00360-X","volume":"404","author":"C Eng","year":"2024","unstructured":"Eng C, Yoshino T, Ru\u00edz-Garc\u00eda E, Mostafa N, Cann CG, O\u2019Brian B, et al. Colorectal cancer. Lancet. 2024;404:294\u2013310.","journal-title":"Lancet"},{"key":"1826_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.acr.2018.02.004","volume":"138","author":"ST Eblen","year":"2018","unstructured":"Eblen ST. Extracellular-regulated kinases: signaling from Ras to ERK Substrates to control biological outcomes. Adv Cancer Res. 2018;138:99\u2013142.","journal-title":"Adv Cancer Res"},{"key":"1826_CR4","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.33718","volume":"7","author":"AM Unni","year":"2018","unstructured":"Unni AM, Harbourne B, Oh MH, Wild S, Ferrarone JR, Lockwood WW, et al. Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells. Elife. 2018;7:e33718.","journal-title":"Elife"},{"key":"1826_CR5","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1002\/1878-0261.13290","volume":"16","author":"Q Wang","year":"2022","unstructured":"Wang Q, Xu C, Cai R, An W, Yuan H, Xu M. Fbxo45-mediated NP-STEP(46) degradation via K6-linked ubiquitination sustains ERK activity in lung cancer. Mol Oncol. 2022;16:3017\u201333.","journal-title":"Mol Oncol"},{"key":"1826_CR6","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1007\/s00018-016-2297-8","volume":"73","author":"D Lake","year":"2016","unstructured":"Lake D, Corr\u00eaa SA, M\u00fcller J. Negative feedback regulation of the ERK1\/2 MAPK pathway. Cell Mol Life Sci. 2016;73:4397\u2013413.","journal-title":"Cell Mol Life Sci"},{"key":"1826_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.apsb.2018.01.008","volume":"8","author":"F Liu","year":"2018","unstructured":"Liu F, Yang X, Geng M, Huang M. Targeting ERK, an Achilles\u2019 Heel of the MAPK pathway, in cancer therapy. Acta Pharm Sin B. 2018;8:552\u201362.","journal-title":"Acta Pharm Sin B"},{"key":"1826_CR8","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202203005","volume":"223","author":"J Wu","year":"2024","unstructured":"Wu J, Chen Y, Li R, Guan Y, Chen M, Yin H, et al. Synergistic anticancer effect by targeting CDK2 and EGFR-ERK signaling. J Cell Biol. 2024;223:e202203005.","journal-title":"J Cell Biol"},{"key":"1826_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07922-4","volume":"16","author":"X Li","year":"2025","unstructured":"Li X, Wu Y, Guo J, Huang P, Li Q, Gao Z, et al. TRIM31 triggers colorectal carcinogenesis and progression by maintaining YBX1 protein stability through ubiquitination modification. Cell Death Dis. 2025;16:621.","journal-title":"Cell Death Dis"},{"key":"1826_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/neuonc\/noae241","volume":"27","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu F, Li C, Zhang T, Han T, Dai Y, et al. TRIM21-mediated ubiquitination and phosphorylation of ERK1\/2 promotes cell proliferation and drug resistance in pituitary adenomas. Neuro Oncol. 2025;27:727\u201342.","journal-title":"Neuro Oncol"},{"key":"1826_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S1097-2765(02)00519-1","volume":"9","author":"Z Lu","year":"2002","unstructured":"Lu Z, Xu S, Joazeiro C, Cobb MH, Hunter T. The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1\/2. Mol Cell. 2002;9:945\u201356.","journal-title":"Mol Cell"},{"key":"1826_CR12","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-021-00732-8","volume":"23","author":"G Zhu","year":"2021","unstructured":"Zhu G, Herlyn M, Yang X. TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination. Nat Cell Biol. 2021;23:978\u201391.","journal-title":"Nat Cell Biol"},{"key":"1826_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308045","volume":"11","author":"J Huang","year":"2024","unstructured":"Huang J, Yin Q, Wang Y, Zhou X, Guo Y, Tang Y, et al. EZH2 inhibition enhances PD-L1 protein stability through USP22-mediated deubiquitination in colorectal cancer. Adv Sci. 2024;11:e2308045.","journal-title":"Adv Sci"},{"key":"1826_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2141-9","volume":"10","author":"RL Kosinsky","year":"2019","unstructured":"Kosinsky RL, Helms M, Zerche M, Wohn L, Dyas A, Prokakis E, et al. USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer. Cell Death Dis. 2019;10:911.","journal-title":"Cell Death Dis"},{"key":"1826_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2015.28","volume":"1","author":"Z Lin","year":"2015","unstructured":"Lin Z, Tan C, Qiu Q, Kong S, Yang H, Zhao F, et al. Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1. Cell Discov. 2015;1:15028.","journal-title":"Cell Discov"},{"key":"1826_CR16","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1021\/acs.jmedchem.8b00241","volume":"61","author":"J Li","year":"2018","unstructured":"Li J, Li S, Guo J, Li Q, Long J, Ma C, et al. Natural Product Micheliolide (MCL) irreversibly activates pyruvate kinase M2 and suppresses leukemia. J Med Chem. 2018;61:4155\u201364.","journal-title":"J Med Chem"},{"key":"1826_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1986-2","volume":"10","author":"X Xi","year":"2019","unstructured":"Xi X, Liu N, Wang Q, Chu Y, Yin Z, Ding Y, et al. ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K\/AKT pathway in glioma. Cell Death Dis. 2019;10:757.","journal-title":"Cell Death Dis"},{"key":"1826_CR18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2017.04.023","volume":"169","author":"GA Collins","year":"2017","unstructured":"Collins GA, Goldberg AL. The logic of the 26S proteasome. Cell. 2017;169:792\u2013806.","journal-title":"Cell"},{"key":"1826_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc6093","volume":"7","author":"SY Chiang","year":"2021","unstructured":"Chiang SY, Wu HC, Lin SY, Chen HY, Wang CF, Yeh NH, et al. Usp11 controls cortical neurogenesis and neuronal migration through Sox11 stabilization. Sci Adv. 2021;7:eabc6093.","journal-title":"Sci Adv"},{"key":"1826_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"1826_CR21","doi-asserted-by":"publisher","first-page":"724","DOI":"10.15252\/embr.201541392","volume":"17","author":"A Weber","year":"2016","unstructured":"Weber A, Heinlein M, Dengjel J, Alber C, Singh PK, H\u00e4cker G. The deubiquitinase Usp27x stabilizes the BH3-only protein Bim and enhances apoptosis. EMBO Rep. 2016;17:724\u201338.","journal-title":"EMBO Rep"},{"key":"1826_CR22","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1038\/s41401-021-00856-5","volume":"43","author":"L Cai","year":"2022","unstructured":"Cai L, Wu ZR, Cao L, Xu JD, Lu JL, Wang CD, et al. ACT001 inhibits pituitary tumor growth by inducing autophagic cell death via MEK4\/MAPK pathway. Acta Pharmacol Sin. 2022;43:2386\u201396.","journal-title":"Acta Pharmacol Sin"},{"key":"1826_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-023-00462-6","volume":"12","author":"H Deng","year":"2023","unstructured":"Deng H, Liu H, Yang G, Wang D, Luo Y, Li C, et al. ACT001 inhibited CD133 transcription by targeting and inducing Olig2 ubiquitination degradation. Oncogenesis. 2023;12:19.","journal-title":"Oncogenesis"},{"key":"1826_CR24","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.7150\/thno.41498","volume":"10","author":"L Tong","year":"2020","unstructured":"Tong L, Li J, Li Q, Wang X, Medikonda R, Zhao T, et al. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 2020;10:5943\u201356.","journal-title":"Theranostics"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01826-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01826-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01826-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:27:59Z","timestamp":1781832479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01826-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01826-5","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all the participants. All the authors have reviewed and approved the final manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}